In the News
ACP issues new osteoporosis guidance
The new clinical guideline from the College updates its 2017 recommendations on pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults.
Register now for ACP and Annals of Internal Medicine's forum on “Firearm Injury: An Escalating Health Crisis”
The virtual live event will be held on Wednesday, Jan. 11, from 3:30 to 5 p.m. ET.
MKSAP Quiz: Recently identified monoclonal protein
A 61-year-old woman is seen in consultation regarding a recently identified monoclonal protein. Medical history is notable for rheumatoid arthritis that has been stable for several years. Following a physical exam and lab tests, what is the most appropriate management?
Missed, delayed diagnoses of primary hyperparathyroidism linked to worse symptoms
More than half of patients with hypercalcemia didn't have their parathyroid hormone levels checked, and more than a third of those who did undergo measurement and were found to have elevated levels still did not receive a diagnosis, a retrospective cohort study found.
DOACs more effective, cost-effective than LMWH for cancer-associated thrombosis
A meta-analysis compared three direct oral anticoagulants (DOACs) (apixaban, edoxaban, and rivaroxaban) to low-molecular-weight heparin (LMWH) and found that apixaban was usually the most cost-effective option, but that finding hinged on the specific drug price.
Put words in our mouth
ACP Internist Weekly wants readers to create captions for our new cartoon and help choose the winner. Pen the winning caption and win a $50 gift certificate good toward any ACP product, program, or service.